Patent details

Basic Information

Publication number:

EP1567152

PCT Application Number:

PCT/US/2003/036288

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP037834223

PCT Publication Number:

WO/2004/045515

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

USE OF RASAGILINE WITH RILUZOLE TO TREAT AMYOTROPHIC LATERAL SCLEROSIS

French Title of Invention:

UTILISATION DE LA RASAGILINE AVEC DU RILUZOLE POUR TRAITER LA SCLEROSE LATERALE AMYOTROPHIQUE

German Title of Invention:

VERWENDUNG VON RASAGILIN MIT RILUZOL ZUR BEHANDLUNG DER AMYOTROPHENLATERALSKLEROSE

SPC Number:

Dates

Filing date:

13/11/2003

Grant date:

14/08/2013

EP Publication Date:

14/08/2013

PCT Publication Date:

03/06/2004

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

31/08/2005

EP B1 Publication Date:

14/08/2013

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

13/11/2018

Expiration date:

13/11/2023

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

13/11/2003

 

 

Name:

Teva Pharmaceutical Industries Limited

Address:

5 Basel Street, Box 3190, Petah Tikvah 49131, Israel (IL)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

25/09/2013

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

LEVY Ruth

Address:

Israel (IL)

2

Name:

BLAUGRUND Eran

Address:

Israel (IL)

Priority

Priority Number:

426543 P

Priority Date:

15/11/2002

Priority Country:

United States (US)

Classification

Main IPC Class:

A61K 31/425;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

20/11/2017

Last Annual Fee Paid Number:

15

Last Annual Fee Paid Amount:

213 Euro

Payer:

DENNEMEYER & CO

Filing date	Document type	Number of pages
30/03/2019	Outgoing Correspondence	1